BMRN

BioMarin Pharmaceutical Inc. - Common Stock (BMRN)

About BioMarin Pharmaceutical Inc. - Common Stock (BMRN)

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Details

Daily high
$56.51
Daily low
$55.45
Price at open
$56.43
52 Week High
$94.85
52 Week Low
$52.93
Market cap
10.8B
Dividend yield
0.00%
Volume
882,459
Avg. volume
2.3M
P/E ratio
20.86

BioMarin Pharmaceutical Inc. - Common Stock News

Details

Daily high
$56.51
Daily low
$55.45
Price at open
$56.43
52 Week High
$94.85
52 Week Low
$52.93
Market cap
10.8B
Dividend yield
0.00%
Volume
882,459
Avg. volume
2.3M
P/E ratio
20.86